Anabolic Steroids and Cardiovascular Outcomes: The Controversy

• Published in: Curēus (Palo Alto, CA) Vol. 12; no. 7; p. e9333
• Main Authors: Perry, Jamal C, Schuetz, Tayná M, Memon, Mohammad D, Faiz, Sadaf, Cancarevic, Ivan
• Format: Journal Article
• Language: English
• Published: Palo Alto Cureus Inc 22.07.2020; Cureus
• Subjects: Anabolic steroids; Atherosclerosis; Blood pressure; Cardiac arrhythmia; Cardiology; Cardiomyopathy; Cardiovascular disease; Coronary vessels; Drug dosages; Drugs & sports; Heart attacks; Heart failure; Hypertension; Lipids; Lipoproteins; Metabolism; Other; Steroids; Testosterone
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.9333

Anabolic steroids (AS) are synthetic derivatives of the male sex hormone testosterone. The use of AS is not limited to bodybuilders and athletes, but non-athletes also use them. It is used to enhance athletic performance, induce muscle hypertrophy, and augment male sexual characteristics. AS use is associated with a wide range of side effects and potential cardiovascular complications. In this article, we have searched the available literature to investigate the association between AS use and cardiovascular disease (CVD). The results revealed that AS was linked to lipid metabolism derangements, hypertension, coagulation disorders, and cardiomyopathy. We concluded, based on the relevant data, that there was evidence that suggests an association with CVD, primarily myocardial infarction, fatal arrhythmias, and cardiomyopathy in AS users. The general population should be informed of the risk. Also, methods of primary and secondary prevention should be implemented to mitigate the risk of CVD secondary to AS.